KBC Group’s Allergan Inc AGN Stock Holding History

KBC Group’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-132,737	Closed	-$28.2M	–	1505
2014 Q4	$28.2M	Buy	132,737 +118,108	+807%	+$23.5M	0.34%	68
2014 Q3	$2.61M	Sell	14,629 -30,226	-67%	-$5.02M	0.09%	289
2014 Q2	$7.59M	Sell	44,855 -16,197	-27%	-$2.52M	0.09%	288
2014 Q1	$7.58M	Buy	61,052 +21,782	+55%	+$2.65M	0.12%	218
2013 Q4	$4.36M	Sell	39,270 -27,875	-42%	-$2.66M	0.07%	338
2013 Q3	$6.07M	Sell	67,145 -4,731	-7%	-$425K	0.1%	269
2013 Q2	$6.05M	Buy	+71,876	New	+$7.46M	0.11%	237

Other funds holding AGN

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return

ECM

Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return

HFS

HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

KBC Group's AGN Position: Q1 2015 in Review

KBC Group sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 132,737 shares — an estimated $28.2M sold.

KBC Group first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $28.2M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

KBC Group reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
KBC Group sold 132,737 Allergan Inc shares in Q1 2015, an estimated $28.2M.
KBC Group first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
KBC Group's Allergan Inc position peaked at $28.2M in Q4 2014.
5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on KBC Group's 13F filing for Q1 2015, filed 30 Apr 2015.